Cargando…

Hypothyroidism is associated with worse outcomes of hepatocellular carcinoma patients after liver transplantation

BACKGROUND/AIMS: Hypothyroidism has been associated with hepatocellular carcinoma (HCC) incidence; however, the relationship between hypothyroidism and HCC patient outcomes is unclear. We investigated the impact of hypothyroidism on outcomes after liver transplantation for HCC. MATERIALS AND METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ning, Jin, Weidong, Zhou, Shuangnan, Yang, Ju Dong, Harmsen, William S., Giama, Nasra H., Wongjarupong, Nicha, Heimbach, Julie K., Watt, Kymberly D., Malhi, Harmeet, Therneau, Terry M., Roberts, Lewis R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308061/ https://www.ncbi.nlm.nih.gov/pubmed/30453389 http://dx.doi.org/10.1002/cam4.1797

Ejemplares similares

Association between variants in inflammation and cancer-associated genes and risk and survival of cholangiocarcinoma
por: Chaiteerakij, Roongruedee, et al.
Publicado: (2015)

Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models
por: Wongjarupong, Nicha, et al.
Publicado: (2018)

Distribution and Incidence of Blood-Borne Infection among Blood Donors from Regional Transfusion Centers in Burkina Faso: A Comprehensive Study
por: Wongjarupong, Nicha, et al.
Publicado: (2021)

Prognostic utility of systemic inflammatory markers and chronic hepatitis C virus infection status in hepatocellular carcinoma patients treated with local ablation
por: Ali, Mohamed Abdulwahab Mohamed, et al.
Publicado: (2022)

Never Too Soon: An Unusual Case of Intrahepatic Cholestasis of Pregnancy at Five Weeks Gestation
por: Wongjarupong, Nicha, et al.
Publicado: (2020)

Everolimus Is Associated With Less Weight Gain Than Tacrolimus 2 Years After Liver Transplantation: Results of a Randomized Multicenter Study
por: Charlton, Michael, et al.
Publicado: (2017)

Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA
por: Hlady, Ryan A., et al.
Publicado: (2019)

3437 Associations of aspirin, non-aspirin NSAIDs, statins, and metformin with risk of biliary cancer: A Swedish population-based cohort study
por: Bonilla, Lorena Marcano, et al.
Publicado: (2019)

Acute Cholecystitis Complicated with Gallbladder Perforation and Peritonitis Caused by Vancomycin-resistant Lactobacillus paracasei
por: Lee, Christina, et al.
Publicado: (2020)

Molecular and Morphological Evidence of Hepatotoxicity after Silver Nanoparticle Exposure: A Systematic Review, In Silico, and Ultrastructure Investigation
por: Sooklert, Kanidta, et al.
Publicado: (2019)

Isolated Asymptomatic Metastatic Melanoma to the Colon: A Case Report
por: Laoveeravat, Passisd, et al.
Publicado: (2019)

Non-invasive tests for predicting liver outcomes in chronic hepatitis C patients: A systematic review and meta-analysis
por: Yongpisarn, Tanat, et al.
Publicado: (2021)

Incidental Finding of Hepatic Inflammatory Pseudotumor Immunoglobulin G4-Related Disease With Underlying Chronic Hepatitis C
por: Delbrune, Malique, et al.
Publicado: (2023)

Higher methylation subtype of malignant melanoma and its correlation with thicker progression and worse prognosis
por: Yamamoto, Yosuke, et al.
Publicado: (2020)

Hemoperitoneum From Bleeding Intra-Abdominal Varices: A Rare, Life-Threatening Cause of Abdominal Pain in a Patient With Cirrhosis
por: Wongjarupong, Nicha, et al.
Publicado: (2021)

Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinoma
por: Zhen, Limin, et al.
Publicado: (2020)

Uridine phosphorylase 1 is a novel immune‐related target and predicts worse survival in brain glioma
por: Wang, Jin, et al.
Publicado: (2020)

High expression of ZNF703 independent of amplification indicates worse prognosis in patients with luminal B breast cancer
por: Reynisdottir, Inga, et al.
Publicado: (2013)

Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
por: Park, Joong-Won, et al.
Publicado: (2015)

Potential Role of Inflammation-Promoting Biliary Microbiome in Primary Sclerosing Cholangitis and Cholangiocarcinoma
por: Miyabe, Katsuyuki, et al.
Publicado: (2022)

Predictors of hepatic decompensation after TACE for hepatocellular carcinoma
por: Kohla, Mohamed A S, et al.
Publicado: (2015)

Clusterin role in hepatocellular carcinoma patients treated with oxaliplatin
por: Wang, Xiumei, et al.
Publicado: (2020)

Inflammatory processes involved in NASH-related hepatocellular carcinoma
por: Cannito, Stefania, et al.
Publicado: (2023)

Worse characteristics can predict survival effectively in bilateral primary breast cancer: A competing risk nomogram using the SEER database
por: Shen, Kaiwen, et al.
Publicado: (2019)

Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis
por: Wongjarupong, Nicha, et al.
Publicado: (2017)

Design and rationale of the HCC BRIDGE study in China: a longitudinal, multicenter cohort trial in hepatocellular carcinoma
por: Chen, Minshan, et al.
Publicado: (2011)

Statin use and the prognosis of patients with hepatocellular carcinoma: a meta-analysis
por: Li, Xiaofei, et al.
Publicado: (2020)

Current progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma
por: Yin, Xiaoqiang, et al.
Publicado: (2022)

High prevalence of chronic viral hepatitis B and C in Minnesota Somalis contributes to rising hepatocellular carcinoma incidence
por: Mohamed, Essa A, et al.
Publicado: (2022)

mTOR up-regulation of SNRPA1 contributes to hepatocellular carcinoma development
por: Feng, Jing, et al.
Publicado: (2020)

Identification of a thirteen-gene signature predicting overall survival for hepatocellular carcinoma
por: Zhou, Xiaohan, et al.
Publicado: (2021)

Coexpression of CD5 and CD43 predicts worse prognosis in diffuse large B‐cell lymphoma
por: Ma, Xiao‐bo, et al.
Publicado: (2018)

Worse capecitabine treatment outcome in patients with a low skeletal muscle mass is not explained by altered pharmacokinetics
por: Molenaar‐Kuijsten, Laura, et al.
Publicado: (2021)

FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma
por: Zhong, Cheng‐Qian, et al.
Publicado: (2018)

Hypothyroidism does not lead to worse prognosis in COVID-19: findings from the Brazilian COVID-19 registry
por: Pereira, Daniella Nunes, et al.
Publicado: (2022)

A qualitative signature for early diagnosis of hepatocellular carcinoma based on relative expression orderings
por: Ao, Lu, et al.
Publicado: (2018)

Development and validation of a nomogram for assessing survival in patients with hepatocellular carcinoma after hepatectomy
por: Huo, Rong-Rui, et al.
Publicado: (2020)

Development and validation of LRP1B mutation-associated prognostic model for hepatocellular carcinoma
por: Xu, Jian, et al.
Publicado: (2021)

Evaluation of anticancer effects of Juniperus communis extract on hepatocellular carcinoma cells in vitro and in vivo
por: Huang, Nan-Chieh, et al.
Publicado: (2021)

Identification of PPT1 as a lysosomal core gene with prognostic value in hepatocellular carcinoma
por: Tian, Wei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1bn13b6imlk6ekadthhcobobk1